Drug Discovery Outsourcing-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Drug Discovery Outsourcing-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Drug Discovery Outsourcing industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Global Drug Discovery Outsourcing Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Drug Discovery Outsourcing Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Libraries
Building Blocks
Compound Synthesis
Target Validation
Global Drug Discovery Outsourcing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Chemistry Services
Biology Services
Lead Optimisation
Lead Identification and Screening
Global Drug Discovery Outsourcing Market: Manufacturers Segment Analysis (Company and Product introduction, Drug Discovery Outsourcing Sales Volume, Revenue, Price and Gross Margin):
Albany Mlecular Research (AMRI)
Aptuit
Charles River Labratries
Cvance
Cyprtex
Dmainex
Evtec
GenScript
Pharmaceutical Prduct Develpment (PPD)
Quintiles
Selcia
Viva Bitech
WIL Research Labratries
WuXi AppTec
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Drug Discovery Outsourcing-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Drug Discovery Outsourcing industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
- Worldwide and Top 20 Countries Market Size of Drug Discovery Outsourcing 2013-2017, and development forecast 2018-2023
- Main manufacturers/suppliers of Drug Discovery Outsourcing worldwide and market share by regions, with company and product introduction, position in the Drug Discovery Outsourcing market
- Market status and development trend of Drug Discovery Outsourcing by types and applications
- Cost and profit status of Drug Discovery Outsourcing, and marketing status
- Market growth drivers and challenges
Global Drug Discovery Outsourcing Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Drug Discovery Outsourcing Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Libraries
Building Blocks
Compound Synthesis
Target Validation
Global Drug Discovery Outsourcing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Chemistry Services
Biology Services
Lead Optimisation
Lead Identification and Screening
Global Drug Discovery Outsourcing Market: Manufacturers Segment Analysis (Company and Product introduction, Drug Discovery Outsourcing Sales Volume, Revenue, Price and Gross Margin):
Albany Mlecular Research (AMRI)
Aptuit
Charles River Labratries
Cvance
Cyprtex
Dmainex
Evtec
GenScript
Pharmaceutical Prduct Develpment (PPD)
Quintiles
Selcia
Viva Bitech
WIL Research Labratries
WuXi AppTec
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF DRUG DISCOVERY OUTSOURCING
1.1 Definition of Drug Discovery Outsourcing in This Report
1.2 Commercial Types of Drug Discovery Outsourcing
1.2.1 Libraries
1.2.2 Building Blocks
1.2.3 Compound Synthesis
1.2.4 Target Validation
1.3 Downstream Application of Drug Discovery Outsourcing
1.3.1 Chemistry Services
1.3.2 Biology Services
1.3.3 Lead Optimisation
1.3.4 Lead Identification and Screening
1.4 Development History of Drug Discovery Outsourcing
1.5 Market Status and Trend of Drug Discovery Outsourcing 2013-2023
1.5.1 Global Drug Discovery Outsourcing Market Status and Trend 2013-2023
1.5.2 Regional Drug Discovery Outsourcing Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Drug Discovery Outsourcing 2013-2017
2.2 Sales Market of Drug Discovery Outsourcing by Regions
2.2.1 Sales Volume of Drug Discovery Outsourcing by Regions
2.2.2 Sales Value of Drug Discovery Outsourcing by Regions
2.3 Production Market of Drug Discovery Outsourcing by Regions
2.4 Global Market Forecast of Drug Discovery Outsourcing 2018-2023
2.4.1 Global Market Forecast of Drug Discovery Outsourcing 2018-2023
2.4.2 Market Forecast of Drug Discovery Outsourcing by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Drug Discovery Outsourcing by Types
3.2 Sales Value of Drug Discovery Outsourcing by Types
3.3 Market Forecast of Drug Discovery Outsourcing by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Drug Discovery Outsourcing by Downstream Industry
4.2 Global Market Forecast of Drug Discovery Outsourcing by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Drug Discovery Outsourcing Market Status by Countries
5.1.1 North America Drug Discovery Outsourcing Sales by Countries (2013-2017)
5.1.2 North America Drug Discovery Outsourcing Revenue by Countries (2013-2017)
5.1.3 United States Drug Discovery Outsourcing Market Status (2013-2017)
5.1.4 Canada Drug Discovery Outsourcing Market Status (2013-2017)
5.1.5 Mexico Drug Discovery Outsourcing Market Status (2013-2017)
5.2 North America Drug Discovery Outsourcing Market Status by Manufacturers
5.3 North America Drug Discovery Outsourcing Market Status by Type (2013-2017)
5.3.1 North America Drug Discovery Outsourcing Sales by Type (2013-2017)
5.3.2 North America Drug Discovery Outsourcing Revenue by Type (2013-2017)
5.4 North America Drug Discovery Outsourcing Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Drug Discovery Outsourcing Market Status by Countries
6.1.1 Europe Drug Discovery Outsourcing Sales by Countries (2013-2017)
6.1.2 Europe Drug Discovery Outsourcing Revenue by Countries (2013-2017)
6.1.3 Germany Drug Discovery Outsourcing Market Status (2013-2017)
6.1.4 UK Drug Discovery Outsourcing Market Status (2013-2017)
6.1.5 France Drug Discovery Outsourcing Market Status (2013-2017)
6.1.6 Italy Drug Discovery Outsourcing Market Status (2013-2017)
6.1.7 Russia Drug Discovery Outsourcing Market Status (2013-2017)
6.1.8 Spain Drug Discovery Outsourcing Market Status (2013-2017)
6.1.9 Benelux Drug Discovery Outsourcing Market Status (2013-2017)
6.2 Europe Drug Discovery Outsourcing Market Status by Manufacturers
6.3 Europe Drug Discovery Outsourcing Market Status by Type (2013-2017)
6.3.1 Europe Drug Discovery Outsourcing Sales by Type (2013-2017)
6.3.2 Europe Drug Discovery Outsourcing Revenue by Type (2013-2017)
6.4 Europe Drug Discovery Outsourcing Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Drug Discovery Outsourcing Market Status by Countries
7.1.1 Asia Pacific Drug Discovery Outsourcing Sales by Countries (2013-2017)
7.1.2 Asia Pacific Drug Discovery Outsourcing Revenue by Countries (2013-2017)
7.1.3 China Drug Discovery Outsourcing Market Status (2013-2017)
7.1.4 Japan Drug Discovery Outsourcing Market Status (2013-2017)
7.1.5 India Drug Discovery Outsourcing Market Status (2013-2017)
7.1.6 Southeast Asia Drug Discovery Outsourcing Market Status (2013-2017)
7.1.7 Australia Drug Discovery Outsourcing Market Status (2013-2017)
7.2 Asia Pacific Drug Discovery Outsourcing Market Status by Manufacturers
7.3 Asia Pacific Drug Discovery Outsourcing Market Status by Type (2013-2017)
7.3.1 Asia Pacific Drug Discovery Outsourcing Sales by Type (2013-2017)
7.3.2 Asia Pacific Drug Discovery Outsourcing Revenue by Type (2013-2017)
7.4 Asia Pacific Drug Discovery Outsourcing Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Drug Discovery Outsourcing Market Status by Countries
8.1.1 Latin America Drug Discovery Outsourcing Sales by Countries (2013-2017)
8.1.2 Latin America Drug Discovery Outsourcing Revenue by Countries (2013-2017)
8.1.3 Brazil Drug Discovery Outsourcing Market Status (2013-2017)
8.1.4 Argentina Drug Discovery Outsourcing Market Status (2013-2017)
8.1.5 Colombia Drug Discovery Outsourcing Market Status (2013-2017)
8.2 Latin America Drug Discovery Outsourcing Market Status by Manufacturers
8.3 Latin America Drug Discovery Outsourcing Market Status by Type (2013-2017)
8.3.1 Latin America Drug Discovery Outsourcing Sales by Type (2013-2017)
8.3.2 Latin America Drug Discovery Outsourcing Revenue by Type (2013-2017)
8.4 Latin America Drug Discovery Outsourcing Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Drug Discovery Outsourcing Market Status by Countries
9.1.1 Middle East and Africa Drug Discovery Outsourcing Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Drug Discovery Outsourcing Revenue by Countries (2013-2017)
9.1.3 Middle East Drug Discovery Outsourcing Market Status (2013-2017)
9.1.4 Africa Drug Discovery Outsourcing Market Status (2013-2017)
9.2 Middle East and Africa Drug Discovery Outsourcing Market Status by Manufacturers
9.3 Middle East and Africa Drug Discovery Outsourcing Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Drug Discovery Outsourcing Sales by Type (2013-2017)
9.3.2 Middle East and Africa Drug Discovery Outsourcing Revenue by Type (2013-2017)
9.4 Middle East and Africa Drug Discovery Outsourcing Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF DRUG DISCOVERY OUTSOURCING
10.1 Global Economy Situation and Trend Overview
10.2 Drug Discovery Outsourcing Downstream Industry Situation and Trend Overview
CHAPTER 11 DRUG DISCOVERY OUTSOURCING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Drug Discovery Outsourcing by Major Manufacturers
11.2 Production Value of Drug Discovery Outsourcing by Major Manufacturers
11.3 Basic Information of Drug Discovery Outsourcing by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Drug Discovery Outsourcing Major Manufacturer
11.3.2 Employees and Revenue Level of Drug Discovery Outsourcing Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 DRUG DISCOVERY OUTSOURCING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Albany Mlecular Research (AMRI)
12.1.1 Company profile
12.1.2 Representative Drug Discovery Outsourcing Product
12.1.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Albany Mlecular Research (AMRI)
12.2 Aptuit
12.2.1 Company profile
12.2.2 Representative Drug Discovery Outsourcing Product
12.2.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Aptuit
12.3 Charles River Labratries
12.3.1 Company profile
12.3.2 Representative Drug Discovery Outsourcing Product
12.3.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Charles River Labratries
12.4 Cvance
12.4.1 Company profile
12.4.2 Representative Drug Discovery Outsourcing Product
12.4.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Cvance
12.5 Cyprtex
12.5.1 Company profile
12.5.2 Representative Drug Discovery Outsourcing Product
12.5.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Cyprtex
12.6 Dmainex
12.6.1 Company profile
12.6.2 Representative Drug Discovery Outsourcing Product
12.6.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Dmainex
12.7 Evtec
12.7.1 Company profile
12.7.2 Representative Drug Discovery Outsourcing Product
12.7.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Evtec
12.8 GenScript
12.8.1 Company profile
12.8.2 Representative Drug Discovery Outsourcing Product
12.8.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of GenScript
12.9 Pharmaceutical Prduct Develpment (PPD)
12.9.1 Company profile
12.9.2 Representative Drug Discovery Outsourcing Product
12.9.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Pharmaceutical Prduct Develpment (PPD)
12.10 Quintiles
12.10.1 Company profile
12.10.2 Representative Drug Discovery Outsourcing Product
12.10.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Quintiles
12.11 Selcia
12.11.1 Company profile
12.11.2 Representative Drug Discovery Outsourcing Product
12.11.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Selcia
12.12 Viva Bitech
12.12.1 Company profile
12.12.2 Representative Drug Discovery Outsourcing Product
12.12.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Viva Bitech
12.13 WIL Research Labratries
12.13.1 Company profile
12.13.2 Representative Drug Discovery Outsourcing Product
12.13.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of WIL Research Labratries
12.14 WuXi AppTec
12.14.1 Company profile
12.14.2 Representative Drug Discovery Outsourcing Product
12.14.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of WuXi AppTec
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG DISCOVERY OUTSOURCING
13.1 Industry Chain of Drug Discovery Outsourcing
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF DRUG DISCOVERY OUTSOURCING
14.1 Cost Structure Analysis of Drug Discovery Outsourcing
14.2 Raw Materials Cost Analysis of Drug Discovery Outsourcing
14.3 Labor Cost Analysis of Drug Discovery Outsourcing
14.4 Manufacturing Expenses Analysis of Drug Discovery Outsourcing
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Drug Discovery Outsourcing in This Report
1.2 Commercial Types of Drug Discovery Outsourcing
1.2.1 Libraries
1.2.2 Building Blocks
1.2.3 Compound Synthesis
1.2.4 Target Validation
1.3 Downstream Application of Drug Discovery Outsourcing
1.3.1 Chemistry Services
1.3.2 Biology Services
1.3.3 Lead Optimisation
1.3.4 Lead Identification and Screening
1.4 Development History of Drug Discovery Outsourcing
1.5 Market Status and Trend of Drug Discovery Outsourcing 2013-2023
1.5.1 Global Drug Discovery Outsourcing Market Status and Trend 2013-2023
1.5.2 Regional Drug Discovery Outsourcing Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Drug Discovery Outsourcing 2013-2017
2.2 Sales Market of Drug Discovery Outsourcing by Regions
2.2.1 Sales Volume of Drug Discovery Outsourcing by Regions
2.2.2 Sales Value of Drug Discovery Outsourcing by Regions
2.3 Production Market of Drug Discovery Outsourcing by Regions
2.4 Global Market Forecast of Drug Discovery Outsourcing 2018-2023
2.4.1 Global Market Forecast of Drug Discovery Outsourcing 2018-2023
2.4.2 Market Forecast of Drug Discovery Outsourcing by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Drug Discovery Outsourcing by Types
3.2 Sales Value of Drug Discovery Outsourcing by Types
3.3 Market Forecast of Drug Discovery Outsourcing by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Drug Discovery Outsourcing by Downstream Industry
4.2 Global Market Forecast of Drug Discovery Outsourcing by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Drug Discovery Outsourcing Market Status by Countries
5.1.1 North America Drug Discovery Outsourcing Sales by Countries (2013-2017)
5.1.2 North America Drug Discovery Outsourcing Revenue by Countries (2013-2017)
5.1.3 United States Drug Discovery Outsourcing Market Status (2013-2017)
5.1.4 Canada Drug Discovery Outsourcing Market Status (2013-2017)
5.1.5 Mexico Drug Discovery Outsourcing Market Status (2013-2017)
5.2 North America Drug Discovery Outsourcing Market Status by Manufacturers
5.3 North America Drug Discovery Outsourcing Market Status by Type (2013-2017)
5.3.1 North America Drug Discovery Outsourcing Sales by Type (2013-2017)
5.3.2 North America Drug Discovery Outsourcing Revenue by Type (2013-2017)
5.4 North America Drug Discovery Outsourcing Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Drug Discovery Outsourcing Market Status by Countries
6.1.1 Europe Drug Discovery Outsourcing Sales by Countries (2013-2017)
6.1.2 Europe Drug Discovery Outsourcing Revenue by Countries (2013-2017)
6.1.3 Germany Drug Discovery Outsourcing Market Status (2013-2017)
6.1.4 UK Drug Discovery Outsourcing Market Status (2013-2017)
6.1.5 France Drug Discovery Outsourcing Market Status (2013-2017)
6.1.6 Italy Drug Discovery Outsourcing Market Status (2013-2017)
6.1.7 Russia Drug Discovery Outsourcing Market Status (2013-2017)
6.1.8 Spain Drug Discovery Outsourcing Market Status (2013-2017)
6.1.9 Benelux Drug Discovery Outsourcing Market Status (2013-2017)
6.2 Europe Drug Discovery Outsourcing Market Status by Manufacturers
6.3 Europe Drug Discovery Outsourcing Market Status by Type (2013-2017)
6.3.1 Europe Drug Discovery Outsourcing Sales by Type (2013-2017)
6.3.2 Europe Drug Discovery Outsourcing Revenue by Type (2013-2017)
6.4 Europe Drug Discovery Outsourcing Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Drug Discovery Outsourcing Market Status by Countries
7.1.1 Asia Pacific Drug Discovery Outsourcing Sales by Countries (2013-2017)
7.1.2 Asia Pacific Drug Discovery Outsourcing Revenue by Countries (2013-2017)
7.1.3 China Drug Discovery Outsourcing Market Status (2013-2017)
7.1.4 Japan Drug Discovery Outsourcing Market Status (2013-2017)
7.1.5 India Drug Discovery Outsourcing Market Status (2013-2017)
7.1.6 Southeast Asia Drug Discovery Outsourcing Market Status (2013-2017)
7.1.7 Australia Drug Discovery Outsourcing Market Status (2013-2017)
7.2 Asia Pacific Drug Discovery Outsourcing Market Status by Manufacturers
7.3 Asia Pacific Drug Discovery Outsourcing Market Status by Type (2013-2017)
7.3.1 Asia Pacific Drug Discovery Outsourcing Sales by Type (2013-2017)
7.3.2 Asia Pacific Drug Discovery Outsourcing Revenue by Type (2013-2017)
7.4 Asia Pacific Drug Discovery Outsourcing Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Drug Discovery Outsourcing Market Status by Countries
8.1.1 Latin America Drug Discovery Outsourcing Sales by Countries (2013-2017)
8.1.2 Latin America Drug Discovery Outsourcing Revenue by Countries (2013-2017)
8.1.3 Brazil Drug Discovery Outsourcing Market Status (2013-2017)
8.1.4 Argentina Drug Discovery Outsourcing Market Status (2013-2017)
8.1.5 Colombia Drug Discovery Outsourcing Market Status (2013-2017)
8.2 Latin America Drug Discovery Outsourcing Market Status by Manufacturers
8.3 Latin America Drug Discovery Outsourcing Market Status by Type (2013-2017)
8.3.1 Latin America Drug Discovery Outsourcing Sales by Type (2013-2017)
8.3.2 Latin America Drug Discovery Outsourcing Revenue by Type (2013-2017)
8.4 Latin America Drug Discovery Outsourcing Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Drug Discovery Outsourcing Market Status by Countries
9.1.1 Middle East and Africa Drug Discovery Outsourcing Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Drug Discovery Outsourcing Revenue by Countries (2013-2017)
9.1.3 Middle East Drug Discovery Outsourcing Market Status (2013-2017)
9.1.4 Africa Drug Discovery Outsourcing Market Status (2013-2017)
9.2 Middle East and Africa Drug Discovery Outsourcing Market Status by Manufacturers
9.3 Middle East and Africa Drug Discovery Outsourcing Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Drug Discovery Outsourcing Sales by Type (2013-2017)
9.3.2 Middle East and Africa Drug Discovery Outsourcing Revenue by Type (2013-2017)
9.4 Middle East and Africa Drug Discovery Outsourcing Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF DRUG DISCOVERY OUTSOURCING
10.1 Global Economy Situation and Trend Overview
10.2 Drug Discovery Outsourcing Downstream Industry Situation and Trend Overview
CHAPTER 11 DRUG DISCOVERY OUTSOURCING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Drug Discovery Outsourcing by Major Manufacturers
11.2 Production Value of Drug Discovery Outsourcing by Major Manufacturers
11.3 Basic Information of Drug Discovery Outsourcing by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Drug Discovery Outsourcing Major Manufacturer
11.3.2 Employees and Revenue Level of Drug Discovery Outsourcing Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 DRUG DISCOVERY OUTSOURCING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Albany Mlecular Research (AMRI)
12.1.1 Company profile
12.1.2 Representative Drug Discovery Outsourcing Product
12.1.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Albany Mlecular Research (AMRI)
12.2 Aptuit
12.2.1 Company profile
12.2.2 Representative Drug Discovery Outsourcing Product
12.2.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Aptuit
12.3 Charles River Labratries
12.3.1 Company profile
12.3.2 Representative Drug Discovery Outsourcing Product
12.3.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Charles River Labratries
12.4 Cvance
12.4.1 Company profile
12.4.2 Representative Drug Discovery Outsourcing Product
12.4.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Cvance
12.5 Cyprtex
12.5.1 Company profile
12.5.2 Representative Drug Discovery Outsourcing Product
12.5.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Cyprtex
12.6 Dmainex
12.6.1 Company profile
12.6.2 Representative Drug Discovery Outsourcing Product
12.6.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Dmainex
12.7 Evtec
12.7.1 Company profile
12.7.2 Representative Drug Discovery Outsourcing Product
12.7.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Evtec
12.8 GenScript
12.8.1 Company profile
12.8.2 Representative Drug Discovery Outsourcing Product
12.8.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of GenScript
12.9 Pharmaceutical Prduct Develpment (PPD)
12.9.1 Company profile
12.9.2 Representative Drug Discovery Outsourcing Product
12.9.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Pharmaceutical Prduct Develpment (PPD)
12.10 Quintiles
12.10.1 Company profile
12.10.2 Representative Drug Discovery Outsourcing Product
12.10.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Quintiles
12.11 Selcia
12.11.1 Company profile
12.11.2 Representative Drug Discovery Outsourcing Product
12.11.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Selcia
12.12 Viva Bitech
12.12.1 Company profile
12.12.2 Representative Drug Discovery Outsourcing Product
12.12.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Viva Bitech
12.13 WIL Research Labratries
12.13.1 Company profile
12.13.2 Representative Drug Discovery Outsourcing Product
12.13.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of WIL Research Labratries
12.14 WuXi AppTec
12.14.1 Company profile
12.14.2 Representative Drug Discovery Outsourcing Product
12.14.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of WuXi AppTec
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG DISCOVERY OUTSOURCING
13.1 Industry Chain of Drug Discovery Outsourcing
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF DRUG DISCOVERY OUTSOURCING
14.1 Cost Structure Analysis of Drug Discovery Outsourcing
14.2 Raw Materials Cost Analysis of Drug Discovery Outsourcing
14.3 Labor Cost Analysis of Drug Discovery Outsourcing
14.4 Manufacturing Expenses Analysis of Drug Discovery Outsourcing
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
